It will only be possible to properly assess how long to use the
drug through a largescale randomized clinical trial. Evaluating
the longterm risks of using clopidogrel was outside of the scope
of this research. Do the
current data support a
recommendation for an extended duration of dual antiplatelet
therapy? We may come back in new and improved form in the future,
but.
